Ryan Splittgerber

627 total citations
8 papers, 445 citations indexed

About

Ryan Splittgerber is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ryan Splittgerber has authored 8 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Ryan Splittgerber's work include NF-κB Signaling Pathways (4 papers), Melanoma and MAPK Pathways (4 papers) and interferon and immune responses (1 paper). Ryan Splittgerber is often cited by papers focused on NF-κB Signaling Pathways (4 papers), Melanoma and MAPK Pathways (4 papers) and interferon and immune responses (1 paper). Ryan Splittgerber collaborates with scholars based in United States and Canada. Ryan Splittgerber's co-authors include Ann Richmond, Sara Kantrow, Jinming Yang, Gregory D. Ayers, Fiona E. Yull, Michael Karin, Yee Mon Thu, Dale Benos, Shanta Sarfare and Niren Kapoor and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Oncogene.

In The Last Decade

Ryan Splittgerber

8 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Splittgerber United States 6 166 112 83 77 67 8 445
Niren Kapoor United States 12 337 2.0× 21 0.2× 83 1.0× 109 1.4× 36 0.5× 23 765
Máté Pálfy Germany 8 429 2.6× 29 0.3× 135 1.6× 39 0.5× 26 0.4× 12 797
Jon Mangion United Kingdom 5 241 1.5× 67 0.6× 42 0.5× 69 0.9× 45 0.7× 6 516
Shuichi Ueda Japan 8 233 1.4× 33 0.3× 46 0.6× 63 0.8× 16 0.2× 59 489
Winston Haynes United States 15 480 2.9× 84 0.8× 9 0.1× 72 0.9× 159 2.4× 28 883
Begoña Granadino Spain 18 720 4.3× 18 0.2× 91 1.1× 52 0.7× 54 0.8× 48 1.2k
Kyungjoon Lee United States 8 517 3.1× 17 0.2× 36 0.4× 127 1.6× 21 0.3× 10 682
Hyun Sook Oh South Korea 12 110 0.7× 83 0.7× 6 0.1× 22 0.3× 30 0.4× 40 419
Mounir Errami United States 13 207 1.2× 19 0.2× 104 1.3× 15 0.2× 10 0.1× 18 624
Laura M. McNamee United States 10 132 0.8× 41 0.4× 20 0.2× 11 0.1× 48 0.7× 13 361

Countries citing papers authored by Ryan Splittgerber

Since Specialization
Citations

This map shows the geographic impact of Ryan Splittgerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Splittgerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Splittgerber more than expected).

Fields of papers citing papers by Ryan Splittgerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Splittgerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Splittgerber. The network helps show where Ryan Splittgerber may publish in the future.

Co-authorship network of co-authors of Ryan Splittgerber

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Splittgerber. A scholar is included among the top collaborators of Ryan Splittgerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Splittgerber. Ryan Splittgerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Splittgerber, Ryan. (2018). Snell's Clinical Neuroanatomy. 2 indexed citations
2.
Su, Yingjun, Anna E. Vilgelm, Mark C. Kelley, et al.. (2012). RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors. Clinical Cancer Research. 18(8). 2184–2198. 47 indexed citations
3.
Liu, Yan, Oriana E. Hawkins, Yingjun Su, et al.. (2012). Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence. EMBO Molecular Medicine. 5(1). 149–166. 78 indexed citations
4.
Thu, Yee Mon, Yan Ru Su, Jinming Yang, et al.. (2011). NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway. Oncogene. 31(20). 2580–2592. 40 indexed citations
5.
Raman, Dayanidhi, et al.. (2011). Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity. Toxicology and Applied Pharmacology. 256(3). 300–313. 28 indexed citations
6.
Thu, Yee Mon, Yingjun Su, Jinming Yang, Ryan Splittgerber, & Ann Richmond. (2011). Abstract 2889: NF-κB inducing kinase modulates melanoma tumorigenesis by regulating pro-survival factors through β-catenin. Cancer Research. 71(8_Supplement). 2889–2889. 1 indexed citations
7.
Yang, Jinming, Ryan Splittgerber, Fiona E. Yull, et al.. (2010). Conditional ablation of Ikkb inhibits melanoma tumor development in mice. Journal of Clinical Investigation. 120(7). 2563–2574. 77 indexed citations
8.
Benos, Dale, J. M. Chaves, Amit Gaggar, et al.. (2007). The ups and downs of peer review. AJP Advances in Physiology Education. 31(2). 145–152. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026